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Edited by Gianni CesareniAbstract Identiﬁcation of pre-B-cell colony-enhancing factor
(PBEF) interacting partners may reveal new molecular mecha-
nisms of PBEF in the pathogenesis of acute lung injury (ALI).
The interactions between PBEF and NADH dehydrogenase sub-
unit 1(ND1), ferritin light chain and interferon induced transmem-
brane 3 (IFITM3) in human pulmonary vascular endothelial cells
were identiﬁed and validated. ND1, ferritin and IFITM3 are in-
volved in oxidative stress and inﬂammation. Overexpression of
PBEF increased its interactions and intracellular oxidative stress,
which can be attenuated by rotenone. The interactionmodeling be-
tween PBEF and ND1 is consistent with the corresponding exper-
imental ﬁnding. These interactions may underlie a novel role of
PBEF in the pathogenesis of ALI.
Structured summary:
MINT-6538697: PBEF (uniprotkb:P43490) physically interacts
(MI:0218) with NADH1 (uniprotkb:P03886) by two hybrid
(MI:0018)
MINT-6538811, MINT-6538868: PBEF (uniprotkb:P43490)
physically interacts (MI:0218) with interferon-induced trans-
membrane protein 3 (uniprotkb:Q01628) by anti bait coimmu-
noprecipitation (MI:0006)
MINT-6538787, MINT-6538841: PBEF (uniprotkb:P43490)
physically interacts (MI:0218) with NADH1 (uni-
protkb:P03886) by anti bait coimmunoprecipitation (MI:0006)
MINT-6538755: PBEF (uniprotkb:P43490) physically interacts
(MI:0218) with c-glutamyl-transferase (uniprotkb:P19440) by
two hybrid (MI:0018)Abbreviation: ALI, acute lung injury; ARDS, acute respiratory distress
syndrome; A2aR, adenosine A2a receptor; ETC, electron transport
chain; EC, endothelial cells; HPAEC, human primary pulmonary
artery endothelial cells; HLMVEC, human primary lung microvascu-
lar endothelial cells; IFITM3, interferon induced transmembrane
protein 3; ND1, NADH dehydrogenase subunit 1; PBEF, Pre-B-cell
colony-enhancing factor; UCE2L6, c-glutamyl transferase and ubiq-
uitin conjugating enzyme E2L6; ROS, reactive oxygen species
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doi:10.1016/j.febslet.2008.04.061MINT-6538799, MINT-6538862:
PBEF (uniprotkb:P43490) physically interacts (MI:0218)with
Ferritin light chain (uniprotkb:P02792) by anti bait coimmuno-
precipitation (MI:0006)
MINT-6538769:
PBEF (uniprotkb:P43490) physically interacts (MI:0218) with
E2L6 (uniprotkb:O14933) by two hybrid (MI:0018)
MINT-6538741:
PBEF (uniprotkb:P43490) physically interacts (MI:0218) with
Adenosine A2aR (uniprotkb:P29274) by two hybrid (MI:0018)
MINT-6538727:
PBEF (uniprotkb:P43490) physically interacts (MI:0218) with
interferon-induced transmembrane protein 3 (uniprotkb:Q01628)
by two hybrid (MI:0018)
MINT-6538712:
PBEF (uniprotkb:P43490) physically interacts (MI:0218) with
Ferritin light chain (uniprotkb:P02792) by two hybrid
(MI:0018)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Acute lung injury (ALI) and its more severe form, acute
respiratory distress syndrome (ARDS), are characterized by
refractory hypoxemia associated with lung inﬂammation and
increased pulmonary vascular permeability [1]. Although
ARDS was ﬁrst described by Ashbaugh and colleagues in
the Lancet in 1967 [2] and considerable progress has been
made, mortality of patients with ALI and ARDS remains
30–50%. This is because molecular mechanisms underlying
the susceptibility and the severity of ARDS are still incom-
pletely understood. Therefore, more studies are clearly needed
to identify novel biochemical and genetic markers and eluci-
date their molecular involvements in ARDS.
In our previous study on animal models of ALI, we identi-
ﬁed preB-cell colony enhancing factor (PBEF) as a signiﬁ-
cantly upregulated gene in ALI [3]. We also found a
susceptible GC haplotype in the human PBEF gene promoter,blished by Elsevier B.V. All rights reserved.
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was conﬁrmed in a separate population by Bajwa et al. [4].
We further found that an inhibition of PBEF expression by
PBEF siRNA signiﬁcantly attenuated pulmonary vascular
endothelial cell barrier dysfunction [5]. Taken together, these
results strongly indicate PBEF as a potential novel candidate
gene and biomarker in ALI.
This study aims to address the molecular mechanisms by
which PBEF contributes to pathogenesis ofALI. Since the inter-
actions between proteins are important for many biological
functions and pathological processes, we applied Bacterio-
Match Two-Hybrid System (Stratagene, La Jolla, CA) [6] to
identify potential human PBEF interacting proteins in the lung.
With this system, several PBEF interacting partner proteins in
the lung were identiﬁed and validated by coimmunoprecipita-
tion experiments in pulmonary vascular endothelial cells. Sev-
eral Interacting proteins to PBEF as well as eﬀect of PBEF on
intracellular oxidative stress were examined in the absence or
presence of IL-1b-stimulation. The computermodeling was also
employed to predict the interacting mode between PBEF and
NADH dehydrogenase subunit 1 (ND1). These results may re-
veal a novel role of PBEF in the pathogenesis of ALI.2. Materials and methods
2.1. Cell culture
Human primary pulmonary artery endothelial cells (HPAEC) and
human primary lung microvascular endothelial cells (HLMVEC) were
obtained from Cambrex Bio Science Inc. (Walkersville, MD). Routine
cell culture and maintenance were performed as described before in our
lab [3,5].
2.2. BacterioMatch Two-Hybrid System screenning
The application of BacterioMatch Two-Hybrid System (Stratagene)
for screening PBEF interacting partners in lung tissues was carried out
according to our established protocol [6]. The PBEF bait was prepared
by subcloning the human PBEF cDNA into the pBait vector, pBT. A
human PBEF coding cDNA prepared before in our lab [7], was PCR
ampliﬁed and inserted in frame into EcoRI and BamHI sites of
the pBT bait plasmid. Primers for the PCR ampliﬁcation are:
5 0-CTAGAATTCATGAATCCTGCGGCAGAAGCCG-3 0and 5 0-
TATGGATCCATGTGCTGCTTCCAGTTCAATAT-30, respectively.
Underlined sequences are EcoRI and BamHI adapters, respectively.
The target lung protein cDNA library in the target vector, pTRG,
was obtained from the Stratagene.2.3. Immunoprecipitation and complex analysis
Immunoprecipitation was performed as described before [8]. HPAEC
and HLMVEC were grown to conﬂuence and incubated in serum-free
media with or without IL-1b (10 ng/ml) for 4 h. The cell lysate samples
were immunoprecipitated with either rabbit anti-PBEF antibody (Beth-
yl Laboratory Inc.), mouse anti-ND1 antibody (Mitoscience), rabbit
anti-Ferritin light chain antibody (ADI), mouse anti-IFITM3 antibody
(Abnova), rabbit anti-A2aR antibody (Chemicon), mouse anti-c-glut-
amyl-transferase antibody (Lab Vision) or mouse anti-Ubiquitin conju-
gating enzyme E2L 6 antibody (Abnova) followed by incubation with
either goat anti-rabbit or goat anti-mouse conjugated sepharose beads
(Sigma). Immunoprecipitated material and cellular lysates were run on
SDS–PAGE on 4–15% polyacrylamide gels, transfer onto Immobilon
membranes, and developed with speciﬁc primary and secondary anti-
bodies. Visualization of immunoreactive bands was achieved using en-
hanced chemiluminescence (Amersham Biosciences).2.4. Reactive oxygen species assay
HPAEC cells were transfected with the vehicle control (c), PBEF
stealth siRNA (Si), scrambled RNA (Sc), PBEF overexpression (E)
and vector control (V) for 48 h before subjected to the treatmentwithout or with IL-1b (10 ng/ml) for 4 h. A549 cells, a lung Type
II epithelial cell line, were similarly transfected for 48 h before trea-
ted with rotenone (Sigma, MO, USA) (10 lM) for 3 h. Reactive
oxygen species assay in HPAEC cells was carried out according to
the protocol of World Precision Instruments Superoxide/Reactive
Oxygen Species Determination kit (Superluminal, Sarasota, FL,
USA).2.5. The binding mode modeling between PBEF and ND1
We further probed the interaction between PBEF and ND1 by
modeling their binding mode. The structure of human PBEF was
downloaded from the Protein Data Bank [9] [pdb code: 2GVG
[10]]. Because no atomic structure is available for ND1, ND1 was
modeled as follows: ﬁrst, the sequence of human ND1 was extracted
from the GenBank [Accession No.: NP536843, [11]]. Based on the
ND1 sequence, similarity search was then performed against the se-
quences in the Protein Data Bank by using the BLAST program
[12]. It was found that the C-terminal domain of the catalase-perox-
idase KatG (pdb code: 1U2L) has a good sequence similarity with
ND1 near the potential interacting residues (81–85). Next, the over-
all sequence alignment between 1U2L and ND1 was obtained
through the FASTA program [13] provided on the PDB web site
(see Fig. 2 A). Based on the sequence alignment, the protein struc-
ture of ND1 was created from the template structure 1U2L by using
the homology modeling program MODELLER [14]. The con-
structed ND1 structure was then docked to the PBEF structure
(2GVG) by using the protein–protein docking program ZDOCK
2.1 [15]. The best-scored orientation was predicted as the binding
mode (Fig. 3).3. Results
3.1. Several potential PBEF interacting partners in expressed
lung cDNA library identiﬁed by the BacterioMatch Two-
Hybrid System
Because most proteins work as complexes to regulate biolog-
ical and/or pathological processes in cells and tissues, we set
out to determine whether PBEF has any interacting partner
in lung tissues using the BacterioMatch Two-Hybrid System.
Six potential PBEF-interacting proteins in the lung including
their protein accession numbers, involved key biological pro-
cesses, interacting fragments and references are presented in
Table 1. They are ND1, ferritin light chain, interferon induced
transmembrane protein 3 (IFITM3), Adenosine A2a receptor
(A2aR), c-glutamyl transferase and ubiquitin conjugating en-
zyme E2L6 (UCE2L6).3.2. Coimmunoprecipitation conﬁrmation of PBEF interacting
partners identiﬁed by the BacterioMatch Two-Hybrid
System
We next employed a coimmunoprecipitation strategy to con-
ﬁrm whether those potential PBEF interacting partners identi-
ﬁed above were true PBEF interacting partners. As presented
in Fig. 1, all six genes (ND1, ferritin light chain, IFITM3,
A2aR, c-glutamyl transferase and UCE2L6) are expressed in
both HPAEC and HLMVEC (Fig. 1A). However, the coim-
munoprecipitation experiments revealed only ND1, ferritin
light chain and IFITM3 out of the 6 PBEF interacting partners
identiﬁed by the BacterioMatch Two-Hybrid System were con-
ﬁrmed in the precipitation complexed with PBEF (Fig. 1B).
These interactions were highly enhanced in the IL1-b-treated
cells. The reverse coimmunoprecipitation experiments corrob-
orated that only ND1, ferritin light chain and IFITM3 inter-
acted with PBEF (Fig. 1C).
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HPAEC and A549 cells
Since above validated three interacting proteins to PBEF are
involved in oxidative stress and inﬂammation, we examined
whether PBEF expression aﬀects intracellular ROS production
in HPAEC in the presence or absence of IL1-b. As presented in
Fig. 2, Inhibition of PBEF expression by PBEF siRNA signif-
icantly blunted IL-1b induced ROS production compared to
its control [343.43 ± 33.12 (Si + I) vs. 523.33 ± 25.17 (C + I),
n = 4, p < 0.05]. Scramble RNA has no signiﬁcant eﬀect
[475.67 ± 23.02 (Sc + I) vs. 523.33 ± 25.17 (C + I), n = 4, NS].
Overexpression of PBEF signiﬁcantly increased ROS produc-
tion over the control [383.68 ± 16.80 (E) vs. 191 ± 18.52 (C),
n = 4, p < 0.05]. Vector only control has no eﬀect [178 ±
18.36 (V) vs. 191 ± 18.52 (C), n = 4, NS]. Overexpression of
PBEF plus IL1-b treatment also signiﬁcantly augmented
ROS production over vector control plus IL1-b treatment
[730.33 ± 35.64 (E + I) vs. 513 ± 32.51 (V + I), n = 4, p <
0.05]. To examine whether the same phenomenon can be ob-
served in A549 cells, a lung Type II epithelial cell line, we
determined the eﬀect of PBEF overexpression in A549 cells
in the absence or presence of rotenone. As presented in Fig.
3, overexpression of PBEF signiﬁcantly augmented ROS pro-
duction over vector control in A549 cells [345 ± 49.34 vs.
200 ± 53.54, n = 3, p < 0.05] (Fig. 3). However, this eﬀect was
signiﬁcantly attenuated by the treatment of rotenone, a
NADH oxidase complex I inhibitor [22] [182.5 ± 35.94 (E +
rotenone) vs. 345 ± 49.34 (E-rotenone), n = 3, p < 0.01].
3.4. The binding mode modeling between PBEF and ND1
To explore the physical interaction between PBEF and ND1,
we generated a hypothetical three dimensional structure of
ND1 based on its sequence homology to the catalase-peroxi-
dase KatG (Fig. 4A) before docking it to a known three
dimensional structure of PBEF (Fig. 4B). Fig. 3A shows that
the residues 81–85 of ND1 are indeed located in the interface
between ND1 and PBEF. Our docking results predicted that
the following residues of PBEF are within 4.5 A of the residues
81–85 of ND1: F193, D219, S241, V242, P243, A244, A245,
E246, T249, I265, H264, Q268, and F269. These residues
may directly interact with the residues 81–85 of ND1. Most
of the above interacting residues within PBEF are hydropho-
bic.4. Discussion
In this study, we have identiﬁed three interacting partners of
PBEF in human pulmonary artery and microvascular endothe-
lial cells: ND1, Ferritin light chain and IFITM3, using the
BaterioMatch Two-Hybrid System screening and a conﬁrma-
tive coimmunoprecipitation approach. These PBEF interactive
proteins may provide insight into the PBEF-mediated signal
transduction leading to the increased pulmonary vascular dys-
function and the pathogenesis in ALI.
Protein–protein interactions are fundamental to all biological
processes. The determination of protein–protein interactions
provides a framework for understanding pathophysiological
functions of a unknown protein based on its known interacting
partners [23]. This is the so called guilt-by-association principle
[24]. The Yeast Two-Hybrid System, as originally described by
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Fig. 1. Coimmunoprecipitation conﬁrmation of PBEF interacting partners identiﬁed by the BacterioMatch Two-Hybrid System. Both conﬂuent
HPAEC and HLMVEC cells were incubated for 4 hours in the presence and absence of IL1-b (10 ng/ml) and their cell lysates were subjected to
coimmunoprecipitation analyses. (A) Detection of protein expression. Cell lysate proteins were immunodetected with antibodies as indicated. *,
preimmune IgG serves as a negative control. (B) Coimmunoprecipitation. Cell proteins with or without the IL1-b treatment are immunoprecipitated
using 6 diﬀerent antibodies as indicated and then immunodetected using the antibody to PBEF. (C) Reverse coimmunoprecipitation. Cell proteins
with the IL1-b treatment are immunoprecipitated using the antibody to PBEF and then immunodetected using six diﬀerent antibodies as indicated.
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Fig. 2. Eﬀect of PBEF expression on reactive oxygen species (ROS)
production in HPAEC in the presence or absence of IL-1b treatment.
HPAEC culture, transfection, IL-1b treatment and ROS production
assay were carried out as described in the method. Five experimental
groups are: vehicle control (C), PBEF stealth siRNA (Si), scrambled
RNA (Sc), PBEF overexpression (E) and vector control (V). Each
group has its baseline level compared to its IL-1b treatment. Results
from each group are presented as means ± S.D. of four samples from
two separate experiments. Statistical comparative analyses of ROS
production levels between the control and IL-1b treated group were
performed using the unpaired t-test. **P < 0.05.
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Fig. 3. Eﬀect of PBEF expression on ROS production in A549 cells in
the presence or absence of rotenone. A549 cells were transfected with
control, pCAGGS-hPBEF and pCAGGS vector only for 48 h, and
then treated with Rotenone for 3 h. The value of reactive oxygen
species were measured by a TriStar Multimode Reader (LB 941,
Berthold Technologies GnbH & Co., KG, Bad Wildbad, Germany)
following instruction manual of the Superluminol Kit (World
Precision Instruments Inc., Sarasota, FL, USA). Results from each
group are presented as means ± S.D. of three samples from two
separate experiments. Statistical comparative analyses of ROS pro-
duction levels between the control and rotenone treated group were
performed using the unpaired t test. *P < 0.05 and **P < 0.01.
L.Q. Zhang et al. / FEBS Letters 582 (2008) 1802–1808 1805Fields and Song [25], is the most commonly utilized system for
identifying binary protein–protein interactions. We employed
one of its derivatives, BaterioMatch Two-Hybrid System from
Stratagene, which is a faster, simpler and more eﬃcient methodfor detecting protein–protein interactions in vivo [6]. Using
PBEF-pBT bait vector to bait potential interacting partners in
a lung cDNA library in pTRG target vector, we identiﬁed sev-
eral interesting proteins interacting with PBEF as listed in Table
Fig. 4. The interacting modeling between PBEF and ND1. (A) The sequence alignment between human NADH dehydrogenase subunit 1 (ND1) and
the catalase-peroxidase KatG (pdb code: 1U2L). The sequence alignment was performed using the FASTA program [13]. For each alignment row,
the upper line is the sequence of 1U2L and the lower line is that of human ND1. The ‘‘*’’ symbols represent identical amino acid residues. The ‘‘:’’
symbols show residue pairs with positive matrix scores, representing similar sequence alignment according to the FASTA algorithm. (B) The
interacting mode between the PBEF and ND1. The left panel is a ribbon representation. The right panel shows the molecular surface of the same
proteins. PBEF is shown in gold, and ND1 is in magenta. The green part represents residues 81–85 of ND1. This ﬁgure was prepared using the UCSF
Chimera [34,35].
1806 L.Q. Zhang et al. / FEBS Letters 582 (2008) 1802–18081. Using an alternative immunoprecipitation approach, three
out of six positive interacting proteins, ND1, IFITM3 and Fer-
ritin light chain were validated (Fig. 1B). This result was further
corroborated by a reverse coimmunoprecipitation experiment
(Fig. 1C). We initially focused on the validation of potential
PBEF interacting partners in human pulmonary vascular endo-
thelial cells. This is because the disruption of pulmonary endo-
thelial cell barrier occurs during inﬂammatory disease states
such as ALI/ARDS and results in the movement of ﬂuid and
macromolecules into the interstitium and pulmonary air spaces,
which is the cardinal feature in the pathogenesis of ALI [26].
Importantly, our previous ﬁndings provided evidence that
PBEF is critically involved in thrombin-induced lung endothe-
lial cell barrier dysregulation [5]. Further exploration of under-
lyingmolecular mechanisms is warranted. These three identiﬁed
PBEF interacting proteins might help shed light on the PBEF-
mediated signal transduction leading to the increased pulmon-
ary vascular dysfunction and the pathogenesis in ALI.ND1 is among the three PBEF interacting partners validated
in pulmonary vascular endothelial cells. ND1 is encoded by the
mitochondrial DNA between nucleotide pairs 3307 and 4262
[27]. It is one of essential components in the mammalian mito-
chondrial NADH dehydrogenase (complex I), which is the ma-
jor entry point for the electron transport chain (ETC) of
mitochondrial oxidative phosphorylation. ND1 is involved in
electron transfer to ubiquinone. The ETC of the mitochondrial
oxidative phosphorylation, the main mechanism for ATP pro-
duction in mammalian cells, is also the major endogenous
source of the ROS (O2 , H2O2, and OH
), which are toxic
by-products of respiration. This is because when the ETC is
inhibited, the electrons accumulate in the early stages of the
ETC (complex I and CoQ), where they can be donated directly
to molecular oxygen to give superoxide anion ðO2 Þ [28]. Thus,
inhibition of the ETC is likely to increase ROS production and
oxidative stress. This study found that human PBEF physically
interacts with ND1, a process enhanced by the IL1-b induction
L.Q. Zhang et al. / FEBS Letters 582 (2008) 1802–1808 1807(Table 1 and Fig. 1). It is possible that the increased interaction
between PBEF and other proteins during the IL1-b treatment
could simply be a consequence of increased amount of sub-
strate proteins.
Increased PBEF–ND1 interaction could consume ND1, re-
duce its availability from its normal function in the ETC of
mitochondria oxidation and thus contribute to increase ROS
production and oxidative stress. On the other hand, the possi-
bility exists that increased ROS production is due to the
enhancement of NADH oxidase complex I by the increased
interaction between PBEF and ND1, which overwhelms the
rest of ETC, leading to the overproduction of ROS. This
hypothesis is supported by the fact that rotenone, an inhibitor
of NADH oxidase complex I [22], signiﬁcantly attenuated the
production of ROS in PBEF overexpressing A549 cells (Fig.
3). It warrants further exploration to clarify the precise mech-
anism. Oxidative stress is known to increase the permeability
of the endothelial monolayer to ﬂuid, macromolecules and
inﬂammatory cells [29]. Increase permeability of the endothe-
lial monolayer leading to the pulmonary edema is the hallmark
of the pathogenesis of ALI. Oxidative stress can lead to cell in-
jury by various mechanisms [30], including modiﬁcations of
proteins, lipids and DNA. Another PBEF interacting protein,
ferritin, can contribute to maintain iron homeostasis in the
lung [31]. Constant exposure to the atmosphere results in sig-
niﬁcant exposure of the lungs to catalytically active iron. The
lungs have a mechanism for detoxiﬁcation to prevent its asso-
ciated generation of oxidative stress. This includes transport-
ing iron intracellularly and sequestering it in an inactive
form within ferritin. Thus, ferritin serves as a protective gene
by virtue of its antioxidant action. The homeostatic adjust-
ments of ferritin have been shown eﬀective in the protection
of the endothelium against the damaging eﬀects of exogenous
heme and oxidants [32]. By the same token, increased PBEF–
Ferritin interaction could consume ferritin, reduce its availabil-
ity from its normal function in the sequestration of an excess
iron and thus contribute to increase iron-associated ROS pro-
duction and oxidative stress. Indeed, PBEF expression aﬀected
intracellular ROS production (Figs. 2 and 3). Inhibition of
PBEF expression by PBEF siRNA signiﬁcantly blunted the
IL-1b induced ROS production. Overexpression of PBEF sig-
niﬁcantly increased ROS production over the control and
overexpression of PBEF plus IL1-b treatment also signiﬁcantly
augmented ROS production over vector control plus IL1-b
treatment. This result suggests that PBEF expression is in-
volved in both baseline and IL-1b induced ROS production.
PBEF interaction with ND1 and ferritin may underlie the
PBEF involved ROS production. The third PBEF interacting
partner, IFITM3, belongs to a human interferon-inducible
gene family [33]. These genes respond to type I and II interfer-
ons and encode for interferon-induced transmembrane protein
thought to be involved with the homotypic cell adhesion func-
tions of interferon. The signiﬁcance of the PBEF–IFITM3
interaction remains to be explored.
The binding mode modeling between PBEF and ND1 (Fig.
4) shows that the residues 81–85 of ND1 are indeed located as
the interface between ND1 and PBEF, which is consistent with
our experimental ﬁndings by the BaterioMatch Two-Hybrid
System screening (Table 1). Our docking results predicted that
the following residues of PBEF are within 4.5 A of the residues
81–85 of ND1: F193, D219, S241, V242, P243, A244, A245,
E246, T249, I265, H264, Q268, and F269. These residuesmay directly interact with the residues 81–85 of ND1. Because
most of the above interacting residues are hydrophobic, it was
predicted that the hydrophobic forces dominate the interac-
tions between the residues 81–85 of ND1 and PBEF. Despite
the consistency between our predicted interactions and exper-
imental ﬁndings, there exists a limitation in the present model.
That is, the crystal structure of ND1 is not available and the
ND1 structure was constructed by homology modeling though
currently 1U2L is the best template for modeling according to
the BLAST program.
In summary, several PBEF interacting partner proteins in
human lung were identiﬁed using the BacterioMatch Two-Hy-
brid System. Three of them: ND1, ferritin light chain and
interferon induced transmembrane 3 (IFITM3) in human pul-
monary vascular endothelial cells were validate by coimmuno-
precipitation experiments. Their interactions were enhanced in
IL-1b-stimulated pulmonary endothelium. PBEF expression
aﬀected intracellular ROS production. PBEF interaction with
ND1 and ferritin may underlie the PBEF involved ROS pro-
duction, whose eﬀect could be signiﬁcantly attenuated by the
treatment of rotenone, a NADH oxidase complex I inhibitor.
The binding mode modeling between PBEF and ND1 indicates
that the residues 81–85 of ND1 are located as the interface be-
tween ND1 and PBEF, which is consistent with our experi-
mental ﬁndings. These studies suggest that interaction
between PBEF and ND1, or ferritin or IFITM3 may in part
explain the novel role of PBEF in the pulmonary inﬂammatory
process and pathogenesis of ALI.
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